Advancements In RNAi Will Harness Aging Healthcare Demand
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
10 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$74.31
92.6% undervalued intrinsic discount16 Aug
US$5.52
1Y
-65.3%7D
-1.3%